JP2021063058A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021063058A5 JP2021063058A5 JP2020143359A JP2020143359A JP2021063058A5 JP 2021063058 A5 JP2021063058 A5 JP 2021063058A5 JP 2020143359 A JP2020143359 A JP 2020143359A JP 2020143359 A JP2020143359 A JP 2020143359A JP 2021063058 A5 JP2021063058 A5 JP 2021063058A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- amino acid
- seq
- cancer
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023135580A JP7570474B2 (ja) | 2019-09-04 | 2023-08-23 | ヒトｒｏｒ１に対する抗体を含む抗体－薬物コンジュゲートおよびその使用 |
| JP2025135500A JP2025186244A (ja) | 2019-09-04 | 2025-08-15 | ヒトｒｏｒ１に対する抗体を含む抗体－薬物コンジュゲートおよびその使用 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2019-0109807 | 2019-09-04 | ||
| KR1020190109807A KR20210028544A (ko) | 2019-09-04 | 2019-09-04 | 인간 ror1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023135580A Division JP7570474B2 (ja) | 2019-09-04 | 2023-08-23 | ヒトｒｏｒ１に対する抗体を含む抗体－薬物コンジュゲートおよびその使用 |
| JP2025135500A Division JP2025186244A (ja) | 2019-09-04 | 2025-08-15 | ヒトｒｏｒ１に対する抗体を含む抗体－薬物コンジュゲートおよびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021063058A JP2021063058A (ja) | 2021-04-22 |
| JP2021063058A5 true JP2021063058A5 (https=) | 2023-08-31 |
| JP7770760B2 JP7770760B2 (ja) | 2025-11-17 |
Family
ID=74733383
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020143359A Active JP7770760B2 (ja) | 2019-09-04 | 2020-08-27 | ヒトｒｏｒ１に対する抗体を含む抗体－薬物コンジュゲートおよびその使用 |
| JP2023135580A Active JP7570474B2 (ja) | 2019-09-04 | 2023-08-23 | ヒトｒｏｒ１に対する抗体を含む抗体－薬物コンジュゲートおよびその使用 |
| JP2025135500A Pending JP2025186244A (ja) | 2019-09-04 | 2025-08-15 | ヒトｒｏｒ１に対する抗体を含む抗体－薬物コンジュゲートおよびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023135580A Active JP7570474B2 (ja) | 2019-09-04 | 2023-08-23 | ヒトｒｏｒ１に対する抗体を含む抗体－薬物コンジュゲートおよびその使用 |
| JP2025135500A Pending JP2025186244A (ja) | 2019-09-04 | 2025-08-15 | ヒトｒｏｒ１に対する抗体を含む抗体－薬物コンジュゲートおよびその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11707533B2 (https=) |
| EP (2) | EP4588940A3 (https=) |
| JP (3) | JP7770760B2 (https=) |
| KR (1) | KR20210028544A (https=) |
| CN (2) | CN113521300B (https=) |
| AU (2) | AU2020343888A1 (https=) |
| BR (1) | BR112022003589A2 (https=) |
| CA (1) | CA3153069A1 (https=) |
| IL (2) | IL314603A (https=) |
| MX (1) | MX2022002592A (https=) |
| TW (2) | TWI876517B (https=) |
| WO (1) | WO2021044208A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016359230B2 (en) * | 2015-11-25 | 2020-04-23 | Ligachem Biosciences Inc. | Conjugates comprising self-immolative groups and methods related thereto |
| AU2016359235B2 (en) | 2015-11-25 | 2022-09-15 | Ligachem Biosciences Inc. | Antibody-drug conjugates comprising branched linkers and methods related thereto |
| CA3058360A1 (en) | 2017-03-29 | 2018-10-04 | Legochem Biosciences, Inc. | Pyrrolobenzodiazepine dimer prodrug and ligand-linker conjugate compound of the same |
| CN112601555A (zh) | 2018-05-09 | 2021-04-02 | 乐高化学生物科学股份有限公司 | 与抗cd19抗体药物结合物相关的组合物和方法 |
| KR20210028544A (ko) | 2019-09-04 | 2021-03-12 | 주식회사 레고켐 바이오사이언스 | 인간 ror1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도 |
| KR20220158181A (ko) * | 2021-05-21 | 2022-11-30 | 주식회사 레고켐 바이오사이언스 | Ror1 및 b7-h3에 결합하는 항체-약물 접합체 및 그 용도 |
| CN115626949B (zh) * | 2021-07-14 | 2026-04-14 | 南京科默生物医药有限公司 | 一种bet蛋白靶向降解化合物及其制备方法和用途 |
| TW202320858A (zh) | 2021-07-19 | 2023-06-01 | 美商薩諾管理公司 | 免疫接合物及方法 |
| US11806405B1 (en) | 2021-07-19 | 2023-11-07 | Zeno Management, Inc. | Immunoconjugates and methods |
| CN118574845A (zh) * | 2022-01-29 | 2024-08-30 | 杭州中美华东制药有限公司 | 一种靶向ror1的抗体或其抗原结合片段及其应用 |
| CN121471361A (zh) * | 2022-03-09 | 2026-02-06 | 杭州中美华东制药有限公司 | 一种靶向ror1的结合分子及其应用 |
| EP4523704A1 (en) | 2022-05-12 | 2025-03-19 | Hainan Simcere Zaiming Pharmaceutical Co., Ltd. | Camptothecin derivative and ligand-drug conjugate |
| WO2024008112A1 (en) * | 2022-07-06 | 2024-01-11 | Nona Biosciences (Suzhou) Co., Ltd. | Anti-ror1 antibodies |
| AU2023306100A1 (en) * | 2022-07-15 | 2025-02-06 | Abl Bio Inc. | Anti-ror1 antibody, bispecific antibody comprising same, and uses thereof |
| CN119907807A (zh) * | 2022-08-11 | 2025-04-29 | 翰森生物有限责任公司 | 配体-细胞毒性药物偶联物及其药物用途 |
| US20260034237A1 (en) * | 2023-01-11 | 2026-02-05 | Genmab A/S | Linkers, drug linkers and conjugates thereof and methods of using the same |
| TW202444425A (zh) * | 2023-03-23 | 2024-11-16 | 大陸商江蘇恆瑞醫藥股份有限公司 | 抗ror1抗體與pbd類化合物的偶聯物、其製備方法及其應用 |
| CN121175072A (zh) * | 2023-04-11 | 2025-12-19 | 浙江博锐生物制药有限公司 | 抗ror1抗体及其药物偶联物 |
| KR20260046391A (ko) * | 2023-07-31 | 2026-04-07 | 씨에스피씨 메가리스 바이오파마슈티칼 씨오., 엘티디. | 항-ror1 단백질 항체 및 이의 접합체 |
| WO2025039809A1 (zh) * | 2023-08-21 | 2025-02-27 | 上海麦科思生物医药有限公司 | 抗ror1抗体及其用途 |
| WO2025140358A1 (en) * | 2023-12-27 | 2025-07-03 | Genequantum Healthcare (Suzhou) Co., Ltd. | A pharmaceutical composition of anti-fgfr3 antibody drug conjugate and applications thereof |
| CN120829509A (zh) * | 2024-04-18 | 2025-10-24 | 上海医药集团股份有限公司 | 抗ror1抗体、其免疫缀合物及其应用 |
| CN118580358B (zh) * | 2024-08-08 | 2024-11-29 | 南京优宁维生物科技有限公司 | 抗ror1重组单克隆抗体及其制备与应用 |
Family Cites Families (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
| US5112739A (en) | 1988-08-02 | 1992-05-12 | Polaroid Corporation | Enzyme controlled release system |
| DE19512484A1 (de) | 1995-04-04 | 1996-10-17 | Bayer Ag | Kohlenhydratmodifizierte Cytostatika |
| EP0795334B1 (de) | 1996-03-12 | 2006-02-01 | Sanofi-Aventis Deutschland GmbH | Neuartige Prodrugs für die Therapie von Tumoren und entzündlichen Erkrankungen |
| US6218519B1 (en) | 1996-04-12 | 2001-04-17 | Pro-Neuron, Inc. | Compounds and methods for the selective treatment of cancer and bacterial infections |
| JP2001505194A (ja) | 1996-11-05 | 2001-04-17 | ブリストル―マイヤーズ・スクイブ・カンパニー | 分枝ペプチド・リンカー |
| US6759509B1 (en) | 1996-11-05 | 2004-07-06 | Bristol-Myers Squibb Company | Branched peptide linkers |
| AU758575C (en) | 1998-04-30 | 2003-11-20 | Maruha Corporation | Compounds having glucuronic acid derivative and glucosamine derivative in structure thereof, method for producing the compounds, and uses of the compounds |
| JP2006510626A (ja) | 2002-12-05 | 2006-03-30 | シエーリング アクチエンゲゼルシャフト | 増殖疾患の処理における部位特異的供給のためのエポチロン類似体 |
| EP2478912B1 (en) | 2003-11-06 | 2016-08-31 | Seattle Genetics, Inc. | Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy |
| SV2007002227A (es) | 2004-09-10 | 2007-03-20 | Wyeth Corp | Anticuerpos anti-5t4 humanizados y conjugados anticuerpo anti-5t4/calicheamicina ref. 040000-0317637 |
| DK3248613T3 (da) | 2005-07-18 | 2022-03-14 | Seagen Inc | Beta-glucuronid-lægemiddel-linkerkonjugater |
| CN101287500A (zh) | 2005-08-19 | 2008-10-15 | 恩多塞特公司 | 多药物配体缀合物 |
| BRPI0716808A2 (pt) | 2006-09-15 | 2013-11-05 | Enzon Pharmaceuticals Inc | Ligantes poliméricos baseados em lisina |
| KR101512203B1 (ko) | 2006-11-10 | 2015-04-15 | 가부시키가이샤 리부텍쿠 | ｉｎ ｖｉｖｏ 에서 항종양 활성을 갖는 항인간 Ｄｌｋ－１ 항체 |
| CL2007003622A1 (es) | 2006-12-13 | 2009-08-07 | Medarex Inc | Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales. |
| JP5404624B2 (ja) | 2007-08-01 | 2014-02-05 | カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチ | 選択的な抗腫瘍薬として有用なピロロ［２，１−ｃ］［１，４］ベンゾジアゼピン−グリコシドプロドラッグ |
| CA2759733C (en) * | 2009-04-23 | 2019-09-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-human ror1 antibodies |
| WO2011066418A1 (en) | 2009-11-25 | 2011-06-03 | Academia Sinica | The tumor-selective anti-cancer prodrug bqc-g |
| SI2528625T1 (sl) | 2010-04-15 | 2013-11-29 | Spirogen Sarl | Pirolobenzodiazepini in njihovi konjugati |
| FR2960153B1 (fr) | 2010-05-20 | 2012-08-17 | Centre Nat Rech Scient | Nouveaux bras autoreactifs et prodrogues les comprenant |
| US9591882B2 (en) | 2010-08-05 | 2017-03-14 | Robert LaGrand Duffin | Absorbent sleeve |
| EP3828205A1 (en) * | 2010-10-01 | 2021-06-02 | Oxford BioTherapeutics Ltd | Anti-ror1 antibodies |
| GB201020995D0 (en) | 2010-12-10 | 2011-01-26 | Bioinvent Int Ab | Biological materials and uses thereof |
| KR20120107741A (ko) | 2011-03-22 | 2012-10-04 | 한국생명공학연구원 | 패혈증 단백질 치료제의 효능 분석 및 스크리닝 방법 |
| KR101461706B1 (ko) | 2011-04-04 | 2014-11-18 | 한국생명공학연구원 | Ｄｌｋ１ 세포 외 수용성 도메인을 포함하는 액티빈 수용체 타입 2ｂ 억제제 |
| CN103502990A (zh) | 2011-04-29 | 2014-01-08 | 惠普发展公司，有限责任合伙企业 | 用于事件的内存中处理的系统和方法 |
| MX393973B (es) | 2011-05-08 | 2025-03-24 | Legochem Biosciences Inc | Conjugados de proteína-agente activo y método para su preparación. |
| CA2850373C (en) | 2011-10-14 | 2019-07-16 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| EP2800586A1 (en) | 2012-01-03 | 2014-11-12 | Invictus Oncology Pvt. Ltd. | Ligand-targeted molecules and methods thereof |
| CN105189507A (zh) | 2012-12-21 | 2015-12-23 | 斯皮罗根有限公司 | 吡咯并苯并二氮杂卓及其结合物 |
| MX2015012549A (es) | 2013-03-15 | 2016-06-21 | Abbvie Deutschland | Formulaciones de conjugado anticuerpo anti-egfr-farmaco. |
| WO2014194030A2 (en) | 2013-05-31 | 2014-12-04 | Immunogen, Inc. | Conjugates comprising cell-binding agents and cytotoxic agents |
| US20160256561A1 (en) | 2013-10-11 | 2016-09-08 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| NZ758049A (en) | 2013-10-15 | 2024-03-22 | Seagen Inc | Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics |
| EA201691075A1 (ru) | 2013-11-26 | 2016-09-30 | Новартис Аг | Способы оксимной конъюгации с кетон-модифицированными полипептидами |
| KR102442906B1 (ko) | 2013-12-19 | 2022-09-14 | 씨젠 인크. | 표적화된-약물 컨쥬게이트와 함께 사용되는 메틸렌 카바메이트 링커 |
| EP2913064A1 (en) | 2014-02-26 | 2015-09-02 | celares GmbH | Branched drug-linker conjugates for the coupling to biological targeting molecules |
| KR101628872B1 (ko) | 2014-05-28 | 2016-06-09 | 주식회사 레고켐 바이오사이언스 | 자가-희생 기를 포함하는 화합물 |
| TWI751102B (zh) | 2014-08-28 | 2022-01-01 | 美商奇諾治療有限公司 | 對ｃｄ１９具專一性之抗體及嵌合抗原受體 |
| FI3900742T3 (fi) | 2014-09-11 | 2024-08-16 | Seagen Inc | Tertiääristä amiinia sisältävien lääkeaineiden kohdennettu antaminen |
| CN107207553A (zh) | 2014-12-09 | 2017-09-26 | 艾伯维公司 | Bcl‑xl抑制性化合物和包括其的抗体药物缀合物 |
| KR20160080832A (ko) | 2014-12-29 | 2016-07-08 | 주식회사 레고켐 바이오사이언스 | 리피바디 유도체-약물 복합체, 그 제조방법 및 용도 |
| WO2016115345A1 (en) * | 2015-01-14 | 2016-07-21 | The Brigham And Women's Hospital, | Treatment of cancer with anti-lap monoclonal antibodies |
| ES2818103T3 (es) * | 2015-01-16 | 2021-04-09 | Juno Therapeutics Inc | Anticuerpos y receptores de antígenos quiméricos específicos para ROR1 |
| PT3250237T (pt) | 2015-01-30 | 2021-06-30 | Sutro Biopharma Inc | Derivados de hemiasterlina para conjugação e terapêutica |
| US11673957B2 (en) * | 2015-03-10 | 2023-06-13 | Eureka Therapeutics, Inc. | Anti-ROR2 antibodies |
| WO2016187220A2 (en) * | 2015-05-18 | 2016-11-24 | Five Prime Therapeutics, Inc. | Anti-ror1 antibodies |
| WO2017051249A1 (en) * | 2015-09-25 | 2017-03-30 | Legochem Biosciences, Inc. | Compositions and methods related to anti-cd19 antibody drug conjugates |
| WO2017051254A1 (en) | 2015-09-25 | 2017-03-30 | Legochem Biosciences, Inc. | Compositions and methods related to anti-egfr antibody drug conjugates |
| MY196631A (en) | 2015-10-13 | 2023-04-24 | Eureka Therapeutics Inc | Antibody Agents Specific for Human Cd19 and uses Thereof |
| AU2016359235B2 (en) | 2015-11-25 | 2022-09-15 | Ligachem Biosciences Inc. | Antibody-drug conjugates comprising branched linkers and methods related thereto |
| KR102847348B1 (ko) | 2015-11-25 | 2025-08-19 | 주식회사 리가켐바이오사이언스 | 펩타이드 그룹을 포함하는 접합체 및 이와 관련된 제조방법 |
| AU2016359230B2 (en) | 2015-11-25 | 2020-04-23 | Ligachem Biosciences Inc. | Conjugates comprising self-immolative groups and methods related thereto |
| RU2651776C2 (ru) | 2015-12-01 | 2018-04-23 | Общество с ограниченной ответственностью "Международный биотехнологический центр "Генериум" ("МБЦ "Генериум") | Биспецифические антитела против cd3*cd19 |
| UA125718C2 (uk) | 2016-01-20 | 2022-05-25 | Зе Скріппс Ресеарч Інстітьют | Композиції антитіл до ror1 і пов'язані з ними способи |
| KR102618596B1 (ko) | 2016-09-30 | 2023-12-28 | 엘지디스플레이 주식회사 | 터치센서 내장형 표시장치 |
| GB201617466D0 (en) * | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| WO2018083535A1 (en) | 2016-11-04 | 2018-05-11 | Novimmune Sa | Anti-cd19 antibodies and methods of use thereof |
| US20200338210A1 (en) * | 2016-12-22 | 2020-10-29 | Ardeagen Corporation | Anti-ror1 antibody and conjugates thereof |
| HUE056289T2 (hu) | 2017-02-08 | 2022-02-28 | Adc Therapeutics Sa | Pirrolobenzodiazepin-antitest konjugátumok |
| CA3058360A1 (en) | 2017-03-29 | 2018-10-04 | Legochem Biosciences, Inc. | Pyrrolobenzodiazepine dimer prodrug and ligand-linker conjugate compound of the same |
| AR113224A1 (es) * | 2017-04-28 | 2020-02-19 | Novartis Ag | Conjugados de anticuerpo que comprenden un agonista de sting |
| AU2018289581C1 (en) | 2017-06-23 | 2025-01-30 | VelosBio Inc. | ROR1 antibody immunoconjugates |
| KR20190018400A (ko) | 2017-08-14 | 2019-02-22 | 주식회사 레고켐 바이오사이언스 | EGFRvIII에 대한 항체를 포함하는 항체 약물 접합체 |
| CN111278860B (zh) | 2017-09-08 | 2024-03-29 | Y生物股份有限公司 | 抗人dlk1的抗体及其用途 |
| WO2019104289A1 (en) * | 2017-11-27 | 2019-05-31 | Mersana Therapeutics, Inc. | Pyrrolobenzodiazepine antibody conjugates |
| CN112601555A (zh) | 2018-05-09 | 2021-04-02 | 乐高化学生物科学股份有限公司 | 与抗cd19抗体药物结合物相关的组合物和方法 |
| WO2019225777A1 (ko) | 2018-05-23 | 2019-11-28 | 에이비엘바이오 주식회사 | 항-ror1 항체 및 그 용도 |
| EP3936150A4 (en) | 2019-03-06 | 2023-03-29 | LegoChem Biosciences, Inc. | ANTIBODY-DRUG CONJUGATES COMPRISING ANTIBODY AGAINST HUMAN DLK1 AND USE THEREOF |
| KR20210028544A (ko) | 2019-09-04 | 2021-03-12 | 주식회사 레고켐 바이오사이언스 | 인간 ror1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도 |
-
2019
- 2019-09-04 KR KR1020190109807A patent/KR20210028544A/ko not_active Ceased
-
2020
- 2020-07-27 US US16/940,326 patent/US11707533B2/en active Active
- 2020-07-27 CA CA3153069A patent/CA3153069A1/en active Pending
- 2020-07-27 EP EP25169388.3A patent/EP4588940A3/en active Pending
- 2020-07-27 EP EP20861806.6A patent/EP4025257A4/en active Pending
- 2020-07-27 WO PCT/IB2020/000649 patent/WO2021044208A1/en not_active Ceased
- 2020-07-27 MX MX2022002592A patent/MX2022002592A/es unknown
- 2020-07-27 IL IL314603A patent/IL314603A/en unknown
- 2020-07-27 BR BR112022003589A patent/BR112022003589A2/pt unknown
- 2020-07-27 AU AU2020343888A patent/AU2020343888A1/en active Pending
- 2020-08-21 TW TW112133782A patent/TWI876517B/zh active
- 2020-08-21 CN CN202110805667.9A patent/CN113521300B/zh active Active
- 2020-08-21 TW TW109128698A patent/TW202122115A/zh unknown
- 2020-08-21 CN CN202010852078.1A patent/CN112439075A/zh active Pending
- 2020-08-27 JP JP2020143359A patent/JP7770760B2/ja active Active
-
2022
- 2022-02-28 IL IL290979A patent/IL290979A/en unknown
-
2023
- 2023-06-13 US US18/209,299 patent/US20230405139A1/en active Pending
- 2023-08-23 JP JP2023135580A patent/JP7570474B2/ja active Active
-
2024
- 2024-07-25 AU AU2024205092A patent/AU2024205092A1/en active Pending
-
2025
- 2025-08-15 JP JP2025135500A patent/JP2025186244A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021063058A5 (https=) | ||
| JP7570474B2 (ja) | ヒトｒｏｒ１に対する抗体を含む抗体－薬物コンジュゲートおよびその使用 | |
| JP7771235B2 (ja) | 抗－ｃｄ１９抗体薬物複合体に関連する組成物および方法 | |
| EP4321180A1 (en) | Antibody-drug conjugate including antibody against human cldn18.2, and use thereof | |
| JP7664045B2 (ja) | ヒトｄｌｋ１に対する抗体を含む抗体薬物コンジュゲート及びその使用 | |
| JP2021523232A5 (https=) | ||
| AU2020233532B2 (en) | Antibody-drug conjugates including antibody against human DLK1, and use thereof | |
| JP2022522547A5 (https=) | ||
| WO2024189428A1 (en) | Antibody-drug conjugate comprising antibodies against human l1cam and uses thereof | |
| JP2025511705A5 (https=) | ||
| TW202500190A (zh) | 包含抗人類trop2之抗體的抗體-藥物結合物及其用途 | |
| TWI899083B (zh) | 包含針對人ｄｌｋ１的抗體的抗體藥物偶聯物及其用途 | |
| TW202344271A (zh) | 包含針對人ｃｌｄｎ１８．２的抗體的抗體藥物偶聯物及其用途 | |
| RU2801630C2 (ru) | Коньюгаты антитело-лекарственное средство, включающие антитело против человеческого dlk1, и их применение | |
| HK40104908A (zh) | 一种包括针对人cldn18.2的抗体的抗体药物偶联物及其用途 | |
| EA049519B1 (ru) | Конъюгат антитело-лекарственное средство, содержащий антитело к ror1 человека, и его применение | |
| RU2021128538A (ru) | Коньюгаты антитело-лекарственное средство, включающие антитело против человеческого dlk1, и их применение | |
| RU2024133074A (ru) | Конъюгат антитело-лекарственное средство, содержащий антитело к trop2 человека, и его применение | |
| NZ778812B2 (en) | Antibody-drug conjugates including antibody against human dlk1, and use thereof | |
| NZ778812A (en) | Antibody-drug conjugates including antibody against human dlk1, and use thereof | |
| EA052135B1 (ru) | Конъюгат антитело-лекарственное средство, содержащий антитело к ror1 человека, и его применение | |
| HK40117773A (zh) | 包含抗人trop2的抗体的抗体-药物缀合物及其用途 | |
| RU2020140202A (ru) | Композиции и способы, относящиеся к конъюгатам лекарственных средств с антителами против cd19 | |
| RU2025127084A (ru) | Конъюгат антитело-лекарственное средство, содержащий антитела против l1cam человека, и его применение | |
| RU2021137408A (ru) | Конъюгаты антитело-лекарственное средство ингибитора MCL-1 и способы их применения |